InsidersTradesSigma
Total declarations
Companies
▲ Purchases (3 ops.)
▼ Sales (6 ops.)
Insider track record
CEODisclosed buys
3
Disclosed sells
6
T+90 hit rate
100%
T+90 mean return
+26.2%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by Boudreaux Gail, Chairman & CEO. Director active across 4 companies, notably TARGET CORP. In total, 21 reports have been recorded. Breakdown: 3 buys · 6 sells. Total volume traded: €17.1m. History available since 23 September 2021. The latest transaction was disclosed on 17 July 2026 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Boudreaux Gail
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations21 total
2,045 shares@ US$368.250.0009% mcap2.0% of flowCommon StockSEC:0001287920-26-000006:1
Canonical exit: 15 Oct 2026 (T+90)
680 shares@ US$366.410.0003% mcap0.7% of flowCommon StockSEC:0001287920-26-000006:0
Canonical exit: 15 Oct 2026 (T+90)
2,682 shares0Common StockSEC:0001287920-26-000004:0
6,713 shares@ US$294.075.3% of flowCommon StockSEC:0001287920-26-000002:0
2,334 shares@ US$286.071.9% of flowCommon StockSEC:0001287920-25-000005:0
Canonical exit: 16 Oct 2025 (T+90)
2,946 shares0Common StockSEC:0000027419-25-000059:0
10,396 shares@ US$395.5013.3% of flowCommon StockSEC:0001156039-25-000022:0
1,100 shares@ US$498.501.7% of flowCommon StockSEC:0001156039-24-000109:0
20,779 shares@ US$500.3632.3% of flowCommon StockSEC:0001156039-24-000109:1
6,621 shares@ US$501.4010.3% of flowCommon StockSEC:0001156039-24-000109:2
2,250 shares@ US$502.233.5% of flowCommon StockSEC:0001156039-24-000109:3
1,000 shares@ US$503.671.6% of flowCommon StockSEC:0001156039-24-000109:4
2,250 shares@ US$504.273.5% of flowCommon StockSEC:0001156039-24-000109:5
1,873 shares0Common StockSEC:0000027419-24-000085:0
19,256 shares@ US$499.1130.1% of flowCommon StockSEC:0001156039-24-000026:0
1,902 shares0Common StockSEC:0001225208-23-003762:0
2,471 shares@ US$469.033.7% of flowCommon StockSEC:0001156039-23-000024:0
10,000 shares0Common StockSEC:0001156039-22-000094:0
1,432 shares0Common StockSEC:0001225208-22-004492:0
15,352 shares@ US$451.50100.0% of flowCommon StockSEC:0001156039-22-000018:0
514 shares0Common StockSEC:0001225208-21-012556:0
21 of 21 declarations
About Boudreaux Gail
BOUDREAUX GAIL is President and CEO. She is linked to Elevance Health, Inc., TARGET CORP, and Anthem, Inc. She has 21 filings, and across the 21 sampled filings between 2021-09-24 and 2026-07-17, the amounts are EUR 1450474 in buys and EUR 15641597 in sells. The most frequent transaction type is Attribution.
